Table 1 Patient characteristics at study entry (n=50)

From: XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

Characteristic

Patients (%)

Age (years)

 70–75

56

 76–79

32

 ⩾80

12

Gender

 Male

72

 Female

28

ECOG performance status

 0

52

 1

46

 2

2

Location of primary tumour

 Colon

68

 Rectum

28

 Both

4

No. of metastatic sites

 1

74

 ⩾2

26

Differentiation

 Well differentiated

10

 Moderately differentiated

60

 Poorly differentiated

18

 Undetermined/unknown

12

Sites of metastasis

 Liver

64

 Lung

32

 Lymph node

14

 Other

24

  1. ECOG=Eastern Cooperative Oncology Group.
Back to article page